These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1463 related articles for article (PubMed ID: 28478385)

  • 21. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
    Li W; Zhuang T; Wang Z; Wang X; Liu L; Luo Y; Wang R; Li L; Huang W; Wang Z; Yang L; Ding L
    Phytomedicine; 2023 Oct; 119():154982. PubMed ID: 37531904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output.
    Baghdasaryan A; Claudel T; Gumhold J; Silbert D; Adorini L; Roda A; Vecchiotti S; Gonzalez FJ; Schoonjans K; Strazzabosco M; Fickert P; Trauner M
    Hepatology; 2011 Oct; 54(4):1303-12. PubMed ID: 22006858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.
    Li S; Qiu M; Kong Y; Zhao X; Choi HJ; Reich M; Bunkelman BH; Liu Q; Hu S; Han M; Xie H; Rosenberg AZ; Keitel V; Kwon TH; Levi M; Li C; Wang W
    J Am Soc Nephrol; 2018 Nov; 29(11):2658-2670. PubMed ID: 30305310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function.
    Comeglio P; Cellai I; Mello T; Filippi S; Maneschi E; Corcetto F; Corno C; Sarchielli E; Morelli A; Rapizzi E; Bani D; Guasti D; Vannelli GB; Galli A; Adorini L; Maggi M; Vignozzi L
    J Endocrinol; 2018 Aug; 238(2):107-127. PubMed ID: 29945982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acids as regulators of hepatic lipid and glucose metabolism.
    Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
    Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists.
    Miyata S; Kawashima Y; Sakai M; Matsubayashi M; Motoki K; Miyajima Y; Watanabe Y; Chikamatsu N; Taniguchi T; Tokuyama R
    Sci Rep; 2021 Apr; 11(1):9196. PubMed ID: 33911126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.
    Li T; Francl JM; Boehme S; Ochoa A; Zhang Y; Klaassen CD; Erickson SK; Chiang JY
    J Biol Chem; 2012 Jan; 287(3):1861-73. PubMed ID: 22144677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
    Brønden A; Knop FK
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31630179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism.
    Zheng X; Chen T; Jiang R; Zhao A; Wu Q; Kuang J; Sun D; Ren Z; Li M; Zhao M; Wang S; Bao Y; Li H; Hu C; Dong B; Li D; Wu J; Xia J; Wang X; Lan K; Rajani C; Xie G; Lu A; Jia W; Jiang C; Jia W
    Cell Metab; 2021 Apr; 33(4):791-803.e7. PubMed ID: 33338411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism.
    Yan Y; Niu Z; Sun C; Li P; Shen S; Liu S; Wu Y; Yun C; Jiao T; Jia S; Li Y; Fang ZZ; Zhao L; Wang J; Xie C; Jiang C; Li Y; Feng X; Hu C; Jiang J; Ying H
    Nat Commun; 2022 Oct; 13(1):6408. PubMed ID: 36302774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.
    Yusta B; Matthews D; Flock GB; Ussher JR; Lavoie B; Mawe GM; Drucker DJ
    Mol Metab; 2017 Jun; 6(6):503-511. PubMed ID: 28580281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.
    Chiang JYL; Ferrell JM
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G554-G573. PubMed ID: 31984784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.
    McMahan RH; Wang XX; Cheng LL; Krisko T; Smith M; El Kasmi K; Pruzanski M; Adorini L; Golden-Mason L; Levi M; Rosen HR
    J Biol Chem; 2013 Apr; 288(17):11761-70. PubMed ID: 23460643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal bile acid receptors are key regulators of glucose homeostasis.
    Trabelsi MS; Lestavel S; Staels B; Collet X
    Proc Nutr Soc; 2017 Aug; 76(3):192-202. PubMed ID: 27846919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid receptors in non-alcoholic fatty liver disease.
    Li Y; Jadhav K; Zhang Y
    Biochem Pharmacol; 2013 Dec; 86(11):1517-24. PubMed ID: 23988487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid metabolism and signaling in liver disease and therapy.
    Chiang JYL
    Liver Res; 2017 Jun; 1(1):3-9. PubMed ID: 29104811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functions of Cholesterol Metabolites.
    Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S151-3. PubMed ID: 26598835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation.
    Miyazaki-Anzai S; Masuda M; Kohno S; Levi M; Shiozaki Y; Keenan AL; Miyazaki M
    J Lipid Res; 2018 Sep; 59(9):1709-1713. PubMed ID: 29976576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.